Dr. Martin is a member of the firm’s Patent Group.
Prior to joining Morrison & Foerster, he was a postdoctoral scientist at the U.S. Army Medical Research Institute of Chemical Defense, where he directed efforts to establish a synthetic organic chemistry laboratory and worked on the design and discovery of small-molecule medical countermeasures to chemical threats. Dr. Martin’s experience also includes postdoctoral work at The Scripps Research Institute and The California Institute for Biomedical Research, where his research focused on the development of a stem cell-based high throughput screening assay for the discovery of new drugs to treat irritable bowel disease, as well as the synthesis and evaluation of antibacterial compounds against infectious disease.
Dr. Martin earned his Ph.D. and M.S. degrees in Organic Chemistry and Comparative Pathology, respectively, from the University of California, Davis. His graduate research focused on the total synthesis of marine-derived natural products and methods for the synthesis of gamma-lactams, as well as protocols to generate induced pluripotent stem cells from fibroblasts.
He received his B.S. in biochemistry and molecular biology from the University of California, Davis, where he participated in translational gene therapy and stem cell research studies aimed at the discovery of therapies to treat diseases of the heart, lungs, and blood.
©1996-2018 Morrison & Foerster LLP. All rights reserved.